ArticleWorld journal of surgical oncology2024

The effective duration of systemic therapy and the neutrophil-to-lymphocyte ratio predict the surgical advantage of primary tumor resection in patients with de novo stage IV breast cancer: a retrospective study.

Rie Sugihara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.